Thursday, May 7, 2026
12:45 - 13:45
Hall C
LUNCH SYMPOSIUM
PRESENTED BY
From Implicit to Intentional: Case-Based Insights on Immunosuppression Personalisation
This dynamic and interactive symposium will explore how immunosuppression should be adapted in liver transplantation as clinical risk and status evolve across the patient journey. Through expert insights and a hepatocellular carcinoma (HCC) case-based debate, faculty will examine how pharmacokinetic exposure and patient-specific factors inform real-world immunosuppression strategies and clinical decision-making.
SPEAKERS
Marina Berenguer, Professor of Medicine, Department of Digestive Diseases, Hepatology and Liver Transplantation Unit, La Fe University Hospital and CIBERehd, Valencia, Spain
Hepatologist, responsible of the Hepatology and Liver Transplantation Unit at the Hospital Universitari i Politècnic La Fe, in Valencia, Spain.
Research Coordinator of the accredited group “Hepatology, Hepato-Biliary-Pancreatic Surgery, and Liver Transplantation” within the Biomedical Research Networking Center for Liver and Digestive Diseases (CIBEREHD) and La Fe Research Institute.
Professor of Medicine at the University of Valencia.
Full member of the Royal Academy of Medicine of the Valencian Community.
Nazia Selzner, Transplant Hepatologist and Medical Director of the Living Donor Liver Transplantation, Ajmera Transplant Center, University Health Network, and Professor of Medicine at the University of Toronto, Canada
Professor Nazia Selzner is a Transplant Hepatologist and Medical Director of the Living Donor Liver Transplantation at the Ajmera Transplant Center, University Health Network, and Professor of Medicine at the University of Toronto. Dr. Nazia Selzner is a Scientist at the Institute for Medical Science (IMS) as well as at the Toronto General Research Institute (TGRI).
Professor Selzner graduated from Medical School at the University of Paris VII, France and completed her Gastroenterology training in France. She completed her PhD in 2003 at the University of Paris VII, France, after four years of research fellowship at Duke University Medical Center, Durham, NC and at the University of Zurich, Switzerland.
Her research interest is in on mechanism of ischemia/reperfusion injury of the liver. Her clinical research is focused on access to liver transplantation and living donor liver transplantation. She is recipient of numerous national and international awards and has published extensively in the area of living organ donation, transplantation outcome and reperfusion injury. She is Immediate Past President of International Liver Transplantation Society (ILTS), Associate Editor for Journal of Hepatology and Executive Editor for Transplant International Journal.
Audrey Coilly, Professor of Hepatology at Paris-Saclay University and Head of the Hepatology Department at the Centre Hépato-Biliaire, Paul Brousse Hospital (AP-HP), France
Professor Audrey Coilly also directs the liver transplantation medical program and serves as Vice-Chair of the national Liver Transplant Coordination Committee.
She is actively involved in clinical and translational research and leads clinical research in hepatology within Inserm Unit U1193 “Physiopathogenesis and Treatment of Liver Diseases”, directed by Professor Duclos-Vallée. Her main fields of interest include viral hepatitis, liver transplantation for viral hepatitis, acute liver failure of unknown cause, vascular liver diseases, and metabolic liver diseases.
She plays an active role in several special interest groups of the International Liver Transplantation Society (ILTS), including those dedicated to Acute Liver Failure and Infectious Diseases.
Professor Coilly is an elected member of the National University Council (CNU 2023–2027). She also holds major responsibilities in medical education at Paris-Saclay University, overseeing the second and third years of the medical curriculum and contributing to pedagogical innovation.
She has authored nearly 200 peer-reviewed publications, including numerous national and international multicenter collaborative studies and clinical guidelines. Her work has been cited over 5,400 times, and her current H-index is 36. Over the past decade, she has delivered more than 100 invited lectures at national and international meetings and has chaired numerous scientific sessions.
Thursday, May 7, 2026
12:45 - 13:45
Room K
LUNCH SYMPOSIUM
PRESENTED BY
The Future of Machine Perfusion: Combining Strategies, Optimizing Care, and Expanding Possibilities
The Future of Machine Perfusion: Combining Strategies, Optimizing Care, and Expanding Possibilities brings together leading experts to explore the evolving role of machine perfusion in transplantation. This session will highlight innovative combination approaches, practical optimization strategies across both adult and pediatric settings, and emerging perspectives on viability assessment and future opportunities. Attendees will gain insights into how these advancements are shaping clinical practice and expanding the potential of organ preservation.
SPEAKERS
Damiano Patrono, MD, PhD, FEBS, A.O.U. Città della Salute e della Scienza - Torino (IT)
Research Interests: Investigating advanced techniques and outcomes in liver transplant surgeries; Studying the immune response and rejection mechanisms in organ transplantation; Enhanced recovery after surgery; NRP plus HOPE Clinical Expertise: Liver transplantation, Hepatobiliary Surgery.
Rebeca Mateos, MD, University Hospitals Birmingham
Miss Rebeca Sanabria Mateos is an adult and paediatric consultant liver transplant surgeon at Queen Elizabeth Hospital Birmingham. Her clinical and research interests focus on optimizing graft preservation, evaluating marginal and complex donors, and improving recipient outcomes.
Andrea Schlegel, MD, MBA, Cleveland Clinic Ohio
Research Interests: Dr. Schlegel’s interests include both experimental and clinical research with a focus on organ preservation to improve the utilization of human organs. To ensure utmost safety for transplant recipients, Dr. Schlegel’s lab explores underlying mechanisms of mitochondrial injury and protection throughout the entire journey of an organ from the donor to the recipient. Since 2011 her research is focused on a broad range of topics including the development of new markers to predict organ viability, and underlying mechanisms of ischemia and reperfusion injury triggered by mitochondrial injury and dysfunction Clinical Expertise: Dr. Schlegel specializes in liver transplantation and hepatobiliary surgery Serves as Associated Editor and Reviewer in more than 15 leading journals in the field of surgery and transplantation and has various internal collaborations worldwide with an average number of 20 invited lectures and presentations per year.
Thursday, May 7, 2026
12:45 - 13:45
Room F
LUNCH SYMPOSIUM
PRESENTED BY
Histotripsy in Practice: Real-World Experience, Evidence, and Future Frontiers
Histotripsy is transitioning from innovation to implementation. This symposium will explore real-world multidisciplinary use cases, lessons learned from early clinical experience, and best practices for integration into interventional oncology programs. Faculty will also review recent clinical research and publications, highlight ongoing studies, and share insights into future development plans and anticipated clinical expansion.
SPEAKER
Professor Albert Chan, Director Liver Transplant Center, Queen Mary Hospital, Hong Kong
Professor Albert Chi‑Yan Chan is a leading hepatobiliary and transplant surgeon, serving as Director of the Liver Transplant Center at Queen Mary Hospital. He specializes in living donor liver transplantation and advanced liver cancer surgery, and is internationally recognized for pioneering the world’s first pediatric ALPPS procedure in 2013. His leadership roles include President of the Asian Surgical Association and Chairman of the ILTS Vanguard Committee, and he has authored over 300 peer‑reviewed publications in major surgical journals. [surgery.hku.hk], [hk.linkedin.com]
Friday, May 8, 2026
12:15 - 13:15
Hall C
LUNCH SYMPOSIUM
PRESENTED BY
Embedding NMP in your practice
Chairperson & Moderator
Dr. Peter Friend, Professor of Transplantation, University of Oxford, Co-founder & Chief Medical Officer of OrganOx
SPEAKERS
Dr. Miriam Cortes Cerisuelo
With over a decade of experience in machine perfusion, Dr. Miriam Cortes Cerisuelo currently leads the liver transplant program at Kings College London, where the OrganOx metra has been in use since 2018. Hear how her team has scaled operations, expanded capacity, and driven significant growth across the program.
Dr. Gabriel Oniscu
Dr. Gabriel Oniscu has held leadership positions in different transplant centers across Europe and is the past-president of ESOT (2023-2025). Hear how he launched the NMP program in Stockholm in 2025, how donor acceptance criteria has changed, and how shifting to daytime surgery has impacted cost and is signalling improved patient outcomes.
Dr. Philipp Houben
Dr. Philipp Houben has been leading pioneering work in machine perfusion at the Transplant Organ Recovery Center in Münster. The university clinic Münster was an early adopter of NMP and implemented viability assessment as standard for their liver transplantation program early on. Hear how Dr. Houben was able to set up a reliable and locally funded program and what the benefits of NMP are in a setting of low donation and very marginal organs.